Light-emitting nanoprobes can detect cancer early and track the spread of tiny tumors
Using light-emitting nanoparticles, Rutgers University-New Brunswick scientists have invented a highly effective method to detect tiny tumors and track their spread, potentially leading to earlier cancer detection and more precise treatment.
The technology could improve patient cure rates and survival times.
“We’ve always had this dream that we can track the progression of cancer in real time, and that’s what we’ve done here,” said Prabhas V. Moghe, a corresponding author of the study and distinguished professor of biomedical engineering and chemical and biochemical engineering at Rutgers-New Brunswick. “We’ve tracked the disease in its very incipient stages.”
The study, published online Dec.11 in Nature Biomedical Engineering, shows that the new method is better than magnetic resonance imaging (MRI) and other cancer surveillance technologies. The research team included Rutgers’ flagship research institution (Rutgers University-New Brunswick) and its academic health center (Rutgers Biomedical and Health Sciences, or RBHS).
“The Achilles’ heel of surgical management for cancer is the presence of micro metastases. This is also a problem for proper staging or treatment planning. The nanoprobes described in this paper will go a long way to solving these problems,” said Steven K. Libutti, director of Rutgers Cancer Institute of New Jersey. He is senior vice president of oncology services for RWJBarnabas Health and vice chancellor for cancer programs for Rutgers Biomedical and Health Sciences.
The ability to spot early tumors that are starting to spread remains a major challenge in cancer diagnosis and treatment, as most imaging methods fail to detect small cancerous lesions. But the Rutgers study shows that tiny tumors in mice can be detected with the injection of nanoprobes, which are microscopic optical devices, that emit short-wave infrared light as they travel through the bloodstream – even tracking tiny tumors in multiple organs.
The nanoprobes were significantly faster than MRIs at detecting the minute spread of tiny lesions and tumors in the adrenal glands and bones in mice. That would likely translate to detection months earlier in people, potentially resulting in saved lives, said Vidya Ganapathy, a corresponding author and assistant research professor in the Department of Biomedical Engineering.
“Cancer cells can lodge in different niches in the body, and the probe follows the spreading cells wherever they go,” she said. “You can treat the tumors intelligently because now you know the address of the cancer.”
The technology could be used to detect and track the 100-plus types of cancer, and could be available within five years, Moghe said. Real-time surveillance of lesions in multiple organs should lead to more accurate pre- and post-therapy monitoring of cancer.
“You can potentially determine the stage of the cancer and then figure out what’s the right approach for a particular patient,” he said.
In the future, nanoprobes could be used in any surgeries to mark tissues that surgeons want to remove, the researchers said. The probes could also be used to track the effectiveness of immunotherapy, which includes stimulating the immune system to fight cancer cells.
The Latest on: Cancer detection and tracking
- My partner left me after his cancer diagnosis — only to shack up with my sisteron August 12, 2019 at 10:54 am
It is painful but it would be better to get your life back on track as a single person and move on. My e-leaflet Mending A Broken Heart will help you. Receiving a cancer diagnosis can make someone ...
- Advanced imaging technology for prostate cancer could increase a man’s chances of survivalon August 9, 2019 at 3:47 am
will help him improve an image fusion technique -; currently used clinically to enable biopsies for diagnosis -; without external tracking devices. Right now, Yan said, magnetic resonance (MR) imaging ...
- New breast cancer blood test 100 times more sensitive than similar testson August 7, 2019 at 9:22 pm
It is suggested the blood test could track the efficacy of ... patient's tumor and personalizes the test to detect the specific mutations associated with that cancer. "Fragments of ctDNA shed ...
- New Super-Sensitive Liquid Biopsy Test For Breast Cancer Described As Possible "Game-Changer"on August 7, 2019 at 11:03 am
A new blood test for tracking breast cancer in patients with early ... “By precisely measuring ctDNA, this test can detect the presence of residual cancer, and inform physicians if cancer has been ...
- Using algorithms to track down canceron August 5, 2019 at 5:51 am
However, science is still grappling with the early detection of cancer and other ... The start-up plans to use this method to track down cancer and other complex diseases. The aim is "to improve ...
- Elburn cancer survivor's dirt biking crash led to diagnosis, saved lifeon August 1, 2019 at 1:23 pm
Thomas has been riding dirt bikes on his backyard track since he was 15 years old ... and they told me I had prostate cancer... stage four. So I guess that accident was a good thing," Thomas ...
- Spying on cells' eating habits could aid cancer diagnosison April 8, 2019 at 2:21 pm
Doctors could also use the technology to monitor how patients are responding to treatment, by tracking the molecules that are eaten ... Spying on cells' eating habits could aid cancer diagnosis.
- Tracking cells’ eating habits could aid cancer diagnosison April 8, 2019 at 7:56 am
Scientists from the University of Edinburgh have developed new imaging technology to visualise what cells eat: a tool which could help with the diagnosis and treatment of cancer and other diseases.
- Spying on cell eating habits 'may help cancer diagnosis'on April 8, 2019 at 4:12 am
Scientists have created new imaging technology to visualise what cells eat, which could help with the diagnosis and treatment of diseases such as cancer. Edinburgh University ... are responding to ...
- Alex Trebek announces stage 4 cancer diagnosis: 5 things to know Thursday, March 7on March 7, 2019 at 3:53 am
The average survival rate of stage 4 pancreatic cancer is 4 to 6 months. House Bill 41, also known as Allison’s Law, would establish a pilot program in Forsyth County to allow the use of a GPS ...
via Google News and Bing News